Institute of Cardiovascular Diseases

Kamenitz 21204

0 studies enrolling now · 2 studies all time

What they study most

Angina Pectoris, Coronary Artery Disease, Myocardial Infarction, Type 2 Diabetes Mellitus

Studies at this site

• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina — Completed